Goldman Sachs’s Enlivex Therapeutics ENLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $23.4K | Buy |
|
|||||
|
2024
Q2 | $16.2K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $29.7K | Sell |
|
|||||
|
2023
Q1 | $68.7K | Sell |
|
|||||
|
2022
Q4 | $74.5K | Sell |
|
|||||
|
2022
Q3 | $88K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $68K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $144K | Buy |
|